Table 2.
Glycemic indexes in gastrointestinal cancer patients - Comparison between patients who developed or not venous thromboembolism during chemotherapy
| Whole cohort |
Venous thromboembolism |
P value1 | ||
| Yes (n = 34) | No (n = 308) | |||
| Glycemia (mg/dL), mean ± SD (range) | 107 ± 38 (51-415) | 122 ± 53 (60-339) | 105 ± 36 (51-415) | 0.019 |
| Insulinemia (μIU/mL), median (IQR) | 12.5 (8.8-20.1) | 17.2 (11.9-24.5) | 11.6 (8.7-18.6) | 0.016 |
| HOMA index, median (IQR) | 3.0 (2.0-5.6) | 4.8 (3.0-8.1) | 2.8 (2.0-4.9) | 0.006 |
| HbA1c (%), mean ± SD (range) | 6.1 ± 0.8 (4.3-13.0) | 6.2 ± 0.6 (5.2-8.0) | 6.1 ± 0.8 (4.3-13.0) | 0.436 |
1
Student t-test or Mann-Whitney U test were used for normally distributed or non parametric variables, respectively. IQR: Interquartile range.